Gracell Biotechnologies Inc. (GRCL) — Net Asset Momentum
Gracell Biotechnologies Inc. (GRCL) recorded a net asset momentum of -24.7% as of December 2022, with net assets of $1.38 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Gracell Biotechnologies Inc. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Gracell Biotechnologies Inc. Net Asset Momentum (2018–2022)
This chart tracks Gracell Biotechnologies Inc.'s year-over-year net asset growth across 5 annual reporting periods from 2018 to 2022. The most recent momentum reading is -24.7%, with net assets of $1.38 Billion USD as of December 2022. Read debt load of Gracell Biotechnologies Inc. for a breakdown of total debt and financial obligations.
Annual Net Asset History for Gracell Biotechnologies Inc. (2018–2022)
The table below shows the complete annual net asset history for Gracell Biotechnologies Inc. from 2018 to 2022, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see GRCL market cap.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2022 | $1.38 Billion | $1.66 Billion | $280.51 Million | ▼ -24.7% |
| 2021 | $1.83 Billion | $2.06 Billion | $232.77 Million | ▲ +122.9% |
| 2020 | $819.66 Million | $964.95 Million | $145.29 Million | ▲ +221.0% |
| 2019 | $255.36 Million | $412.22 Million | $156.86 Million | ▲ +10615.7% |
| 2018 | $2.38 Million | $148.52 Million | $146.13 Million | — |